FAPI PET/CT在鼻咽癌靶区勾画中的临床价值
本研究对21例新诊断鼻咽癌患者行18F-AIF-NOTA-FAPI-04 PET/CT,以SUVmax的20%至60%(5%递增)阈值自动勾画原发肿瘤靶区,并与MRI手动勾画比较。结果显示GTV-FAPI 20%、25%、30%与GTV-MRI无显著差异,其中GTV-FAPI 20%与GTV-MRI最接近;FAPI PET/CT在检测原发肿瘤软组织及骨结构受累方面优于MRI。
要点
- 21例新诊断鼻咽癌患者中,GTV-FAPI 20%、25%、30%与GTV-MRI无显著差异。
- GTV-FAPI 20%与GTV-MRI的相似性最高。
- FAPI PET/CT检测原发肿瘤软组织及骨结构受累优于MRI。
核心结论
- 18F-AIF-NOTA-FAPI-04 PET/CT可提高鼻咽癌GTV勾画的精确性,并在T分期中显示临床实用性。
研究设计与样本
- 对21例新诊断鼻咽癌患者行18F-AIF-NOTA-FAPI-04 PET/CT,采用基于阈值的分割方法(SUVmax的20%至60%,5%递增)自动勾画原发肿瘤靶区,并在MRI图像上手动勾画原发肿瘤。
主要发现
- 不同影像方法所得原发肿瘤靶区体积存在差异。
- GTV-FAPI 20%、GTV-FAPI 25%、GTV-FAPI 30%与GTV-MRI相比均无显著差异。
- GTV-FAPI 20%与GTV-MRI的相似性最高。
- 18F-AIF-NOTA-FAPI-04 PET/CT在检测原发肿瘤软组织及骨组织受累方面优于MRI。
关键数值与推荐
- 自动勾画阈值设为SUVmax的20%至60%,以5%递增。
- GTV-FAPI 20%与GTV-MRI最接近。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the efficacy of 18F-AIF-NOTA-FAPI-04 PET/CT in improving the accuracy of target volume delineation in nasopharyngeal carcinoma (NPC). METHODS: Automatic delineation of the primary tumor target volume was conducted for 21 newly diagnosed NPC patients using 18F-AIF-NOTA-FAPI-04 PET/CT images, which applied a threshold-based segmentation with 5% increments from 20 to 60% of SUVmax. Manual delineation of the primary tumor was performed on MRI images. The study analyzed the gross target volumes (GTV) discrepancies between 18F-AIF-NOTA-FAPI-04 PET/CT and MRI. Furthermore, we compared how the two imaging modalities affected the assessment of the primary tumors' involvement of bone-related structures and soft tissue (mucosa) infiltration. RESULTS: There were variations in the primary tumor target volume across the different imaging methods. There were no significant differences observed between GTV-FAPI 20%, GTV-FAPI 25%, and GTV-FAPI 30% compared to GTV-MRI. Among them, GTV-FAPI 20% showed the closest similarity to GTV-MRI. 18F-AIF-NOTA-FAPI-04 PET/CT was superior to MRI in detecting soft tissue and bone tissue involvement in primary tumors. CONCLUSIONS: 18F-AIF-NOTA-FAPI-04 PET/CT enhances precision in delineating GTV for NPC and demonstrates clinical utility in T-staging.
引用
- Xu W, Zou Y, Zhang Y, et al. The clinical value of FAPI PET/CT in delineating target volumes for nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2025. PMID: 40447840. doi:10.1007/s00259-025-07347-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。